NovoArc is a Vienna-based biotech startup (founded in 2021) that develops and produces unique, highly stable ether-lipids for use in pharmaceutical drug formulation and delivery. These specialized lipids protect active pharmaceutical ingredients (APIs), namely small molecules, proteins, and nucleic acids, from degradation (e.g., in the stomach) and boost their bioavailability. NovoArc’s platform uses a patented biotechnological process to generate these ether lipids.